The sequencing and analysis of human DNA have advanced significantly since the initial draft of a human genome that was published as part of the Human Genome Project. With DNA sequencing becoming increasingly cost-effective, the market for genetic testing is growing at an accelerating rate – the market for Next Generation Sequencing (NGS) services has an estimated annual growth of 18.3% from 2022 to 2030. AI presents a range of possibilities for this rapidly growing field, and in this article,
Read More
risk
New Healthcare H2 2022 Data: Reported Breaches Trend Down, But Individuals Affected Skyrocket by 35% to Nearly 29M
What You Should Know: - Critical Insight, the Cybersecurity-as-a-Service provider specializing in helping critical organizations Prepare, Detect, and Respond in today’s threat environment releases its H2 2022 Healthcare Data Breach Report, which analyzes breach data reported to the U.S. Department of Health and Human Services by healthcare organizations. - The number of data breaches affecting healthcare providers declined in the second half of 2022, consistent with a downward trend over
Read More
Vytalize Health Closes $100M to Support Value-Based Care Transformation
What You Should Know: - Vytalize Health, a leading risk-bearing provider enablement platform, announced it has closed $100 million in funding led by Enhanced Healthcare Partners and Monroe Capital, with participation from North Coast Ventures. - Vytalize Health partners with primary care practices for more than 250,000 patients and offers evidence-based recommendations at the point of care. By delivering the right data at the right time in the workflow to physicians and their staff,
Read More
Apixio Launches EHR-Integrated Post-Visit Solution
What You Should Know: - Apixio, a leading AI platform that powers value-based care launches its new Apicare Post-Visit™ offering, an EHR-integrated intelligent workflow solution for health plans and providers. With the Centers for Medicare & Medicaid Services' recent Medicare Advantage Risk Adjustment Data Validation Final Rule, healthcare organizations need to have complete diagnosis capture and accurate documentation for reimbursement to ensure compliance. - The new Post-Visit
Read More
Aledade Acquires Curia, Adds More Than 450 New Practices
What You Should Know: - Aledade today announced the acquisition of Curia, a leader in value-based care analytics using practical applications of artificial intelligence (AI) to optimize the targeting of patient care and engagement programs. The acquisition will enhance Aledade’s ability to extract valuable insights from disparate data sources, provide more accurate predictions using past data, and optimize primary care workflows through cutting-edge AI algorithms. - In addition, the
Read More
Targeted IT Solutions Ease Navigation and Shift to Value-Based Care
The new healthcare realm of value-based care (VBC), designed to reward healthcare providers with incentive payments for the quality of care and patient outcomes not simply the volume of services provided, presents both opportunities and challenges for all stakeholders. This fundamental shift in reimbursement is intended to become part of the larger quality strategy in reforming how healthcare is delivered and compensated: better care for individuals, better health for populations
Read More
How and Why Device-as-a-Service Should Be an Employee Benefit
The Great Resignation changed how companies approach attracting and retaining talent. These days, it’s not enough to offer a competitive salary and traditional benefits like health insurance and a 401k. Employees have put an increased focus on flexibility – and the tools that support it. Phones and tablets aren’t the flashiest perk a company can offer. Still, they’re the type of lifestyle benefit that offers clear value for employees – and helps address pain points for companies
Read More
Report: Pharma R&D ROI Falls to Lowest Level in 13 Years
What You Should Know: - Deloitte Centre for Health Solutions releases its thirteenth annual report, ‘Seize the Digital Momentum: Measuring the return from pharmaceutical innovation 2022’ that explores the performance of the biopharmaceutical industry (bio Pharma) and its ability to generate returns from investment in innovative new medicines. - Since 2021, much of the world has successfully adjusted to life where COVID-19 is more endemic as vaccines and treatments reduced the risk and
Read More
From Telemedicine to Complete Virtual Care and Beyond
Telemedicine has helped improve the quality of life of patients in every corner of the world and has been successfully utilized to provide convenient care to people with limited or no access to health services. Today, worldwide digital interconnectivity is growing, enabling telehealth to advance health equity, bring access to care for underserved regions and meet the urgent, primary and behavioral healthcare needs of an exploding global population. It has been a remarkable journey for the
Read More
HTA to Offer Cognoa’s Canvas Dx Diagnostic Device for Autism to Member Organizations
What You Should Know: - Health Transformation Alliance (HTA), a cooperative of nearly 60 of America’s largest employers, has partnered with Cognoa, a pediatric behavioral health company, to offer the company’s Canvas Dx diagnostic device for autism to all HTA Member organizations and their employees. - HTA will offer its member organizations – some of the most influential and significant brands in the U.S. – the opportunity to add Canvas Dx to their benefit design. Expanding Horizons By
Read More
